Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHABLIS-T II: Tenecteplase in Acute Ischemic Stroke
NCT04516993Phase 2Completed
- Sponsor
- Huashan Hospital
- Start
- Sep 2021
- Primary completion
- Sep 2023
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tenecteplase in ischemic stroke, sponsored by Huashan Hospital. Started Sep 2021; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04516993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516993.